Patent Term Application for ITOVEBI (inavolisib), Patent No. 9,650,393 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-0159

Patent Term Application for ITOVEBI (inavolisib), Patent No. 9,650,393

Documents

Comments

Description

OPEN

Comment Period OpensJan 15, 2025

Type	Title	Posted	Comments	Status
Other	Letter from U.S Patent and Trademark Office to FDA CDER	Mar 25, 2026	--

CDER

Patent Term Application

Morrison & Foerster LLP

Genentech, Inc

ITOVEBI (inavolisib)

Patent No. 9,650,393

OPEN